Javascript must be enabled to continue!
Formulation and Evaluation of Fast Dissolving Sublingual Films of Labetalol Hydrochloride
View through CrossRef
Fast dissolving sublingual film is the type of drug delivery systems which when placed in the sublingual cavity disintegrates or dissolves within few seconds due to presence of saliva in mouth. The present study was undertaken with the objective of formulating and evaluating fast dissolving sublingual films of Labetalol hydrochloride to enhance the patient convenience and compliance specifically elderly and paediatric patients. Fast dissolving sublingual films of Labetalol hydrochloride were prepared by solvent casting method using different concentrations of water-soluble film forming polymers such as HPMC K4M, HPMC and NaCMC. PEG 400 was used as plasticizer. Six formulations were prepared and evaluated for physicochemical parameters such as weight uniformity, thickness, surface pH, tensile strength, swelling index, drug content, disintegration time, in vitro dissolution studies and stability studies. All the formulations showed satisfactory results for the tested parameters. The formulation F3 containing 3wv of HPMC was found to show maximum drug release i.e., 97.711.18 at the end of 300 seconds and found to disintegrate in 191.24 seconds. Thus, fast dissolving sublingual films of Labetalol hydrochloride was an effective approach whenever immediate onset of action is required.
Srinivas University
Title: Formulation and Evaluation of Fast Dissolving Sublingual Films of Labetalol Hydrochloride
Description:
Fast dissolving sublingual film is the type of drug delivery systems which when placed in the sublingual cavity disintegrates or dissolves within few seconds due to presence of saliva in mouth.
The present study was undertaken with the objective of formulating and evaluating fast dissolving sublingual films of Labetalol hydrochloride to enhance the patient convenience and compliance specifically elderly and paediatric patients.
Fast dissolving sublingual films of Labetalol hydrochloride were prepared by solvent casting method using different concentrations of water-soluble film forming polymers such as HPMC K4M, HPMC and NaCMC.
PEG 400 was used as plasticizer.
Six formulations were prepared and evaluated for physicochemical parameters such as weight uniformity, thickness, surface pH, tensile strength, swelling index, drug content, disintegration time, in vitro dissolution studies and stability studies.
All the formulations showed satisfactory results for the tested parameters.
The formulation F3 containing 3wv of HPMC was found to show maximum drug release i.
e.
, 97.
711.
18 at the end of 300 seconds and found to disintegrate in 191.
24 seconds.
Thus, fast dissolving sublingual films of Labetalol hydrochloride was an effective approach whenever immediate onset of action is required.
Related Results
The dose dependency of the alpha‐adrenoceptor antagonist and beta‐ adrenoceptor partial agonist activity of dilevalol and labetalol in man.
The dose dependency of the alpha‐adrenoceptor antagonist and beta‐ adrenoceptor partial agonist activity of dilevalol and labetalol in man.
1. The alpha‐adrenoceptor antagonist, beta 1‐adrenoceptor antagonist and beta 2‐partial agonist activity of dilevalol, a beta‐adrenoceptor antagonist with vasodilating properties a...
Comparative Efficacy of Labetalol and Methyldopa in the Management of Pregnancy-Induced Hypertension
Comparative Efficacy of Labetalol and Methyldopa in the Management of Pregnancy-Induced Hypertension
Background: Pregnancy-induced hypertension (PIH) is a common obstetric complication marked by elevated blood pressure after 20 weeks of gestation, affecting 5–10% of pregnancies wo...
Alternative Entrances: Phillip Noyce and Sydney’s Counterculture
Alternative Entrances: Phillip Noyce and Sydney’s Counterculture
Phillip Noyce is one of Australia’s most prominent film makers—a successful feature film director with both iconic Australian narratives and many a Hollywood blockbuster under his ...
Oral Nifidepine versus IV labetalol in severe preeclampsia: A randomized control trial
Oral Nifidepine versus IV labetalol in severe preeclampsia: A randomized control trial
Objective: To compare oral Nifidepine and IV labetalol in terms of rapidity of BP control in severe preeclampsia.
Methods: All patients coming to Services Hospital from March...
Comparative efficacy and safety of antihypertensive agents in preeclampsia and gestational hypertension uncontrolled and their long-term effects on offspring
Comparative efficacy and safety of antihypertensive agents in preeclampsia and gestational hypertension uncontrolled and their long-term effects on offspring
Background: Hypertensive disorder of pregnancy (HDP), a common obstetric
complication that seriously threatens maternal and infant health. The
current clinical treatment drugs incl...
A Comparative Study of Oral Nifedipine and Intravenous Labetalol for Acute Hypertensive Management in Pregnancy: Assessing Feto-Maternal Outcomes in a Hospital-based Randomized Control Trial
A Comparative Study of Oral Nifedipine and Intravenous Labetalol for Acute Hypertensive Management in Pregnancy: Assessing Feto-Maternal Outcomes in a Hospital-based Randomized Control Trial
Background and Objective
Hypertension is one of the most common medical complications during pregnancy and a leading cause of maternal mo...
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
1. The alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol, a beta‐adrenoceptor antagonist with vasodilating properties, and labetalol were investigated in 10 healthy ma...
Review of long‐term treatment with labetalol.
Review of long‐term treatment with labetalol.
1 Labetalol has been used to treat 163 patients at the Dunedin Hypertension Clinic for periods up to 6.5 y, and of 128 patients in a New Zealand multicentre study for 2 yr. 2 Labet...

